Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia.
Umbilical cord blood (UCB) and bone marrow (BM)-derived stem and progenitor cells possess two characteristics required for successful tissue regeneration: extensive proliferative capacity and the ability to differentiate into multiple cell lineages. Within the normal BM and in pathological condition...
Main Authors: | Martin-Rendon, E, Hale, S, Ryan, D, Baban, D, Forde, S, Roubelakis, M, Sweeney, D, Moukayed, M, Harris, A, Davies, K, Watt, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells.
by: Forde, S, et al.
Published: (2007) -
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
by: Martin-Rendon, E, et al.
Published: (2008) -
hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors.
by: Shunsuke Ohnishi, et al.
Published: (2013-01-01) -
The impact of proliferative potential of umbilical cord-derived endothelial progenitor cells and hypoxia on vascular tubule formation in vitro.
by: Zhang, Y, et al.
Published: (2009) -
Characterization of Megakaryocyte Progenitor Cells Differentiated from Umbilical Cord Blood CD133+ and CD133– Cells
by: Alireza Goodarzi, et al.
Published: (2007-01-01)